{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "25.34",
    "chg": 0.01,
    "chgp": "0.04%",
    "dir": 1,
    "prev_price": "25.33",
    "mcapval": "40.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE584F01014",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1.74 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs and Organics Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-hits-upper-circuit-amid-strong-buying-pressure-3746021",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_stocks_hitting_upper_circuit_3746021.png",
        "date": "2025-12-04 10:00:10",
        "description": "Shares of Mangalam Drugs and Organics Ltd surged to hit the upper circuit limit on 4 December 2025, reflecting robust buying interest and a maximum permissible daily gain of 5%. The stock closed at ₹25.40, marking a significant turnaround after a prolonged period of decline, and outperformed its sector and benchmark indices amid notable market activity."
      },
      {
        "title": "Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-hits-lower-circuit-amid-heavy-selling-pressure-3743480",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_stocks_hitting_lower_circuit_3743480.png",
        "date": "2025-12-03 10:00:08",
        "description": "Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 3 December 2025, reflecting intense selling pressure and a continuation of a prolonged downtrend. The stock recorded its new 52-week low at ₹23.94, marking a significant decline amid subdued investor participation and unfilled supply on the order books."
      },
      {
        "title": "Mangalam Drugs and Organics Falls to 52-Week Low of Rs.24.08 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-falls-to-52-week-low-amidst-continued-downtrend-3743387",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_priceRelatedfactors_3743387.png",
        "date": "2025-12-03 09:49:24",
        "description": "Mangalam Drugs and Organics has reached a new 52-week low of Rs.24.08, marking a significant decline amid a sustained period of negative returns and financial pressures. The stock’s recent performance highlights ongoing challenges within the Pharmaceuticals & Biotechnology sector, as it continues to trade well below key moving averages and underperform its benchmark indices."
      },
      {
        "title": "Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-hits-lower-circuit-amid-heavy-selling-pressure-3741645",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_stocks_hitting_lower_circuit_3741645.png",
        "date": "2025-12-02 11:00:12",
        "description": "Mangalam Drugs and Organics Ltd witnessed a sharp decline on 2 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical and biotechnology company’s shares closed at a new 52-week low of Rs 25.20, marking a maximum daily loss of 5.01%, significantly underperforming its sector and the broader market indices."
      },
      {
        "title": "Mangalam Drugs and Organics Faces Intense Selling Pressure Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-faces-severe-selling-pressure-hits-new-52-week-low-3741560",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_only_sellers_3741560.png",
        "date": "2025-12-02 10:30:15",
        "description": "Mangalam Drugs and Organics Ltd is currently experiencing severe selling pressure, marked by a complete absence of buyers and a persistent decline in its share price. The stock has recorded consecutive losses over an extended period, signalling distress selling within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Mangalam Drugs and Organics Falls to 52-Week Low of Rs.25.85 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-hits-52-week-low-amidst-continued-downtrend-3741094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_priceRelatedfactors_3741094.png",
        "date": "2025-12-02 09:48:44",
        "description": "Mangalam Drugs and Organics has reached a fresh 52-week low of Rs.25.85, marking a significant decline amid an extended period of negative returns and underperformance relative to its sector and broader market indices."
      },
      {
        "title": "Why is Mangalam Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-mangalam-drugs-fallingrising-3739534",
        "imagepath": "",
        "date": "2025-12-02 00:34:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Downtrend and Underperformance Against Benchmarks</strong></p>\n<p>The stock has been on a steep decline over multiple time horizons. Over the past week, Mangalam Drugs has lost 34.16% of its value, while the Sensex gained 0.87%. The one-month performance is even more stark, with the stock plunging 59.56% compared to a 2.03% rise in the benchmark. Year-to-date, the stock has fallen 77.00%, in sharp contrast to the Sensex’s 9.60% gain. Over the last year, the stock’s decline of 78.20% starkly contrasts with the Sensex’s 7.32% appreciation. This underperformance extends to the three- and five-year periods, where Mangalam Drugs has lost over 81% of its value while the Sensex has surged by 35.33% and 91.78% respectively.</p>\n<p><strong>Weak Financial Fundamentals Weighing on Investor C..."
      },
      {
        "title": "Mangalam Drugs and Organics Faces Intense Selling Pressure Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-plunges-to-new-lows-amid-intense-selling-pressure-3738886",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_only_sellers_3738886.png",
        "date": "2025-12-01 15:30:11",
        "description": "Mangalam Drugs and Organics Ltd has encountered severe selling pressure, with the stock hitting a fresh 52-week low and registering a day’s decline of 4.99%, significantly underperforming the broader market and its sector peers. The absence of buyers and a persistent downtrend highlight distress selling signals that have intensified over recent months."
      },
      {
        "title": "Mangalam Drugs and Organics Falls to 52-Week Low of Rs.26.67 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-stock-hits-52-week-low-amidst-continued-downtrend-3738349",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_priceRelatedfactors_3738349.png",
        "date": "2025-12-01 11:09:58",
        "description": "Mangalam Drugs and Organics has reached a new 52-week low of Rs.26.67, marking a significant decline amid a sustained downward trajectory over the past several months. The stock’s recent performance contrasts sharply with broader market trends, highlighting ongoing challenges within the company’s financial and operational landscape."
      }
    ],
    "total": 130,
    "sid": "138636",
    "stock_news_url": "https://www.marketsmojo.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "25-Nov-2025",
      "details": "Intimation of repeat international order clients amounting to approx 15 Crores.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "21-Nov-2025",
      "details": "Newspaper publication for declaration of Un-Audited Financial results (Standalone and Consolidated) for the quarter ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 20Th November 2025 At 12:00 P.M. To Approve Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended 30Th September 2025",
      "datetime": "20-Nov-2025",
      "details": "Intimation of outcome of Board meeting held on 20th November 2025 at 12:00 p.m. to approve standalone and consolidated un-audited financial results of the Company for the quarter ended 30th September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mangalam Drugs and Organics Hits Upper Circuit Amid Strong Buying Pressure

2025-12-04 10:00:10

Shares of Mangalam Drugs and Organics Ltd surged to hit the upper circuit limit on 4 December 2025, reflecting robust buying interest and a maximum permissible daily gain of 5%. The stock closed at ₹25.40, marking a significant turnaround after a prolonged period of decline, and outperformed its sector and benchmark indices amid notable market activity.

Read More

Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-03 10:00:08

Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 3 December 2025, reflecting intense selling pressure and a continuation of a prolonged downtrend. The stock recorded its new 52-week low at ₹23.94, marking a significant decline amid subdued investor participation and unfilled supply on the order books.

Read More

Mangalam Drugs and Organics Falls to 52-Week Low of Rs.24.08 Amidst Prolonged Downtrend

2025-12-03 09:49:24

Mangalam Drugs and Organics has reached a new 52-week low of Rs.24.08, marking a significant decline amid a sustained period of negative returns and financial pressures. The stock’s recent performance highlights ongoing challenges within the Pharmaceuticals & Biotechnology sector, as it continues to trade well below key moving averages and underperform its benchmark indices.

Read More

Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-02 11:00:12

Mangalam Drugs and Organics Ltd witnessed a sharp decline on 2 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical and biotechnology company’s shares closed at a new 52-week low of Rs 25.20, marking a maximum daily loss of 5.01%, significantly underperforming its sector and the broader market indices.

Read More

Mangalam Drugs and Organics Faces Intense Selling Pressure Amid Prolonged Downtrend

2025-12-02 10:30:15

Mangalam Drugs and Organics Ltd is currently experiencing severe selling pressure, marked by a complete absence of buyers and a persistent decline in its share price. The stock has recorded consecutive losses over an extended period, signalling distress selling within the Pharmaceuticals & Biotechnology sector.

Read More

Mangalam Drugs and Organics Falls to 52-Week Low of Rs.25.85 Amidst Prolonged Downtrend

2025-12-02 09:48:44

Mangalam Drugs and Organics has reached a fresh 52-week low of Rs.25.85, marking a significant decline amid an extended period of negative returns and underperformance relative to its sector and broader market indices.

Read More

Why is Mangalam Drugs falling/rising?

2025-12-02 00:34:35

Persistent Downtrend and Underperformance Against Benchmarks

The stock has been on a steep decline over multiple time horizons. Over the past week, Mangalam Drugs has lost 34.16% of its value, while the Sensex gained 0.87%. The one-month performance is even more stark, with the stock plunging 59.56% compared to a 2.03% rise in the benchmark. Year-to-date, the stock has fallen 77.00%, in sharp contrast to the Sensex’s 9.60% gain. Over the last year, the stock’s decline of 78.20% starkly contrasts with the Sensex’s 7.32% appreciation. This underperformance extends to the three- and five-year periods, where Mangalam Drugs has lost over 81% of its value while the Sensex has surged by 35.33% and 91.78% respectively.

Weak Financial Fundamentals Weighing on Investor C...

Read More

Mangalam Drugs and Organics Faces Intense Selling Pressure Amid Prolonged Downtrend

2025-12-01 15:30:11

Mangalam Drugs and Organics Ltd has encountered severe selling pressure, with the stock hitting a fresh 52-week low and registering a day’s decline of 4.99%, significantly underperforming the broader market and its sector peers. The absence of buyers and a persistent downtrend highlight distress selling signals that have intensified over recent months.

Read More

Mangalam Drugs and Organics Falls to 52-Week Low of Rs.26.67 Amidst Prolonged Downtrend

2025-12-01 11:09:58

Mangalam Drugs and Organics has reached a new 52-week low of Rs.26.67, marking a significant decline amid a sustained downward trajectory over the past several months. The stock’s recent performance contrasts sharply with broader market trends, highlighting ongoing challenges within the company’s financial and operational landscape.

Read More

View All News